Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1978 2
1979 6
1980 17
1981 6
1982 13
1983 12
1984 12
1985 21
1986 7
1987 14
1988 19
1989 23
1990 37
1991 18
1992 33
1993 40
1994 33
1995 39
1996 47
1997 39
1998 47
1999 64
2000 43
2001 50
2002 84
2003 84
2004 85
2005 109
2006 92
2007 120
2008 91
2009 81
2010 88
2011 111
2012 105
2013 101
2014 117
2015 119
2016 109
2017 109
2018 122
2019 67
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

2,330 results
Results by year
Filters applied: . Clear all
Page 1
Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward.
West CE, et al. Expert Rev Clin Immunol 2016 - Review. Among authors: Prescott SL. PMID 26821735 Free article.
In an attempt to restore this dysbiosis, probiotics have been evaluated in randomized controlled trials. Here, we review treatment and primary prevention studies, recent meta-analyses, and discuss the current understanding of the role of probiotics in this context. Many meta-analyses have shown a moderate benefit of probiotics for eczema prevention, whereas there is less evidence of a benefit for other allergic manifestations. ...
In an attempt to restore this dysbiosis, probiotics have been evaluated in randomized controlled trials. Here, we review treatment an …
Poison prevention: engineering in primary prevention.
Marcus SM. Clin Toxicol (Phila) 2012 - Review. PMID 22335507
I intend to discuss the approaches to prevention. METHODS: I review various primary, secondary, and tertiary prevention strategies in relationship to poison prevention. CONCLUSIONS: We have made strong efforts in some ways, but our efforts in primary prevention have often been less than maximal. ...
I intend to discuss the approaches to prevention. METHODS: I review various primary, secondary, and tertiary prevention
Potential targets for next generation antimicrobial glycoconjugate vaccines
Micoli F, et al. FEMS Microbiol Rev 2018 - Review. PMID 29547971 Free PMC article.
Cell surface carbohydrates have been proven optimal targets for vaccine development. Conjugation of polysaccharides to a carrier protein triggers a T-cell-dependent immune response to the glycan moiety. Licensed glycoconjugate vaccines are produced by chemical conjugation of capsular polysaccharides to prevent meningitis caused by meningococcus, pneumococcus and Haemophilus influenzae type b. ...
Cell surface carbohydrates have been proven optimal targets for vaccine development. Conjugation of polysaccharides to a carrier p
[Vaccination: What's new?]
Seybold U. Dtsch Med Wochenschr 2018 - Review. PMID 30060278 German.
Vaccination practices in Germany are driven by scientific developments and a complex regulatory environment. Some important developments in 2018 are described here: Starting in 2018 only quadrivalent influenza vaccines will be used for the seasonal vaccination. ...After promising trial results a timely guideline for the use of the newly available adjuvanted subunit zoster vaccine is to be expected. ...
Vaccination practices in Germany are driven by scientific developments and a complex regulatory environment. Some important developme …
Recent advances in the prevention of mental disorders.
Mendelson T and Eaton WW. Soc Psychiatry Psychiatr Epidemiol 2018 - Review. PMID 29546492
Promising areas for further development include internet- or computer-based prevention strategies, mindfulness-based interventions, and integration of prevention programs within occupational settings. ...Using the growing evidence base to inform policy and dissemination of evidence-based prevention programs is critical for moving prevention science into real-world settings....
Promising areas for further development include internet- or computer-based prevention strategies, mindfulness-based intervent
On surmounting the barriers to HPV vaccination: we can do better
Attia AC, et al. Ann Med 2018. PMID 29316825
Finally, acceptability for vaccination of males must improve by increasing provider recommendation and by presenting the HPV vaccine as a penile, anal and oropharyngeal cancer prevention therapy in males and not merely a vaccine to prevent cervical cancers in females. Paediatricians, obstetrician/gynaecologists and primary care physicians should consider these data as a call-to-action. Key messages   • Despite recent efforts in the US, only 49.5% of females and only 37.5% of males ages 13 through 17 have received all recommended HPV vaccine doses. ...
Finally, acceptability for vaccination of males must improve by increasing provider recommendation and by presenting the HPV v …
2,330 results
Jump to page
Feedback